Loading...
•
Mar 31, 2021
10X Genomics Q1 2021 Earnings Report
Reported a revenue increase of 47% compared to the prior year.
Key Takeaways
10x Genomics reported a strong start to the year with a 47% increase in revenue compared to Q1 2020. The company launched new products and capabilities and announced the acquisition of Tetramer Shop.
Revenue was $105.8 million, a 47% increase over the corresponding period of 2020.
Launched Single Cell Gene Expression with CellPlex and Chromium Single Cell Gene Expression Low Throughput Kits.
Showcased new products and capabilities across three product platforms.
Announced the acquisition of Tetramer Shop at the first ever Xperience event in February.
Forward Guidance
10x Genomics is maintaining full year 2021 revenue guidance of $480 million to $500 million, representing 61% to 67% growth over full year 2020 revenue.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...